{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:03:22Z","timestamp":1762646602613,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"vor","delay-in-days":46,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.gastha.2022.02.013","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T05:55:42Z","timestamp":1651211742000},"page":"531-537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Heterologous Effects of Travel Vaccines in Colorectal Cancer: A Database Study and a Cautionary Tale"],"prefix":"10.1016","volume":"1","author":[{"given":"Eva","family":"Herweijer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Schwamborn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaatje","family":"Bollaerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Spillmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Cattaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Verstraeten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0695-5938","authenticated-orcid":false,"given":"Janet","family":"Hoogstraate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2021","series-title":"International tourism, number of arrivals","key":"10.1016\/j.gastha.2022.02.013_bib1"},{"key":"10.1016\/j.gastha.2022.02.013_bib2","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.mayocp.2019.02.025","article-title":"Vaccines for international travel","volume":"94","author":"Freedman","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.gastha.2022.02.013_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tax046","article-title":"What proportion of international travellers acquire a travel-related illness? A review of the literature","volume":"24","author":"Angelo","year":"2017","journal-title":"J\u00a0Travel Med"},{"volume":"Volume 2021","year":"2020","key":"10.1016\/j.gastha.2022.02.013_bib4"},{"key":"10.1016\/j.gastha.2022.02.013_bib6","doi-asserted-by":"crossref","first-page":"6672","DOI":"10.1016\/j.vaccine.2016.10.039","article-title":"Vaccine safety evaluation: practical aspects in assessing benefits and risks","volume":"34","author":"Di Pasquale","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.gastha.2022.02.013_bib7","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1080\/14760584.2019.1676154","article-title":"Challenges in evaluating post-licensure vaccine safety: observations from the Centers for Disease Control and Prevention","volume":"18","author":"Moro","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.gastha.2022.02.013_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tax082","article-title":"Safety of live vaccines on immunosuppressive or immunomodulatory therapy\u2014a retrospective study in three Swiss Travel Clinics","volume":"25","author":"Huber","year":"2018","journal-title":"J\u00a0Travel Med"},{"key":"10.1016\/j.gastha.2022.02.013_bib9","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s11606-010-1609-1","article-title":"Healthy user and related biases in observational studies of preventive interventions: a primer for physicians","volume":"26","author":"Shrank","year":"2011","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.gastha.2022.02.013_bib10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s12879-015-1154-y","article-title":"Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review","volume":"15","author":"Remschmidt","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.gastha.2022.02.013_bib11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1053\/j.gastro.2017.09.009","article-title":"Cholera vaccine use is associated with a reduced risk of death in patients with colorectal cancer: a population-based study","volume":"154","author":"Ji","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2022.02.013_bib12","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1038\/s41467-018-04814-4","article-title":"Association between post-diagnostic use of cholera vaccine and risk of death in prostate cancer patients","volume":"9","author":"Ji","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.gastha.2022.02.013_bib13","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41416-020-01108-9","article-title":"Association of post-diagnostic use of cholera vaccine with survival outcome in breast cancer patients","volume":"124","author":"Zheng","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.gastha.2022.02.013_bib14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41577-020-0338-x","article-title":"The non-specific and sex-differential effects of vaccines","volume":"20","author":"Aaby","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.gastha.2022.02.013_bib15","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nri.2016.43","article-title":"Harnessing the beneficial heterologous effects of vaccination","volume":"16","author":"Goodridge","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.gastha.2022.02.013_bib16","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2217\/fmb-2018-0026","article-title":"Heterologous effects of infant BCG vaccination: potential mechanisms of immunity","volume":"13","author":"Butkeviciute","year":"2018","journal-title":"Future Microbiol"},{"key":"10.1016\/j.gastha.2022.02.013_bib17","doi-asserted-by":"crossref","first-page":"i5170","DOI":"10.1136\/bmj.i5170","article-title":"Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review","volume":"355","author":"Higgins","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.gastha.2022.02.013_bib18","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1016\/j.vaccine.2019.07.059","article-title":"The risk of non-specific hospitalised infections following MMR vaccination given with and without inactivated vaccines in the second year of life. Comparative self\u2013controlled case-series study in England","volume":"37","author":"Andrews","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.gastha.2022.02.013_bib19","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1016\/j.vaccine.2016.11.005","article-title":"Simultaneous vaccination with MMR and DTaP-IPV-Hib and rate of hospital admissions with any infections: a nationwide register based cohort study","volume":"34","author":"S\u00f8rup","year":"2016","journal-title":"Vaccine"},{"year":"2004","series-title":"ICD-10: international statistical classification of diseases and related health problems: tenth revision","key":"10.1016\/j.gastha.2022.02.013_bib20"},{"key":"10.1016\/j.gastha.2022.02.013_bib21","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1200\/JCO.2009.24.0952","article-title":"Revised TN categorization for colon cancer based on national survival outcomes data","volume":"28","author":"Gunderson","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.gastha.2022.02.013_bib22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/14740338.2017.1269168","article-title":"Hydroxychloroquine in systemic lupus erythematosus (SLE)","volume":"16","author":"Ponticelli","year":"2017","journal-title":"Expert Opin Drug Saf"},{"year":"2019","series-title":"R: a language and environment for statistical computing","key":"10.1016\/j.gastha.2022.02.013_bib23"},{"key":"10.1016\/j.gastha.2022.02.013_bib24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00280-016-3197-1","article-title":"Research progress of hydroxychloroquine and autophagy inhibitors on cancer","volume":"79","author":"Shi","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.gastha.2022.02.013_bib25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/EDE.0b013e3181d61eeb","article-title":"Negative controls: a tool for detecting confounding and bias in observational studies","volume":"21","author":"Lipsitch","year":"2010","journal-title":"Epidemiology"},{"key":"10.1016\/j.gastha.2022.02.013_bib26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/CLEP.S129879","article-title":"Confounding in observational studies based on large health care databases: problems and potential solutions - a primer for the clinician","volume":"9","author":"N\u00f8rgaard","year":"2017","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.gastha.2022.02.013_bib27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ije\/dyi274","article-title":"Evidence of bias in estimates of influenza vaccine effectiveness in seniors","volume":"35","author":"Jackson","year":"2006","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.gastha.2022.02.013_bib28","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1080\/07391102.2020.1784291","article-title":"Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease","volume":"39","author":"Kandeel","year":"2020","journal-title":"J\u00a0Biomol Struct Dyn"},{"key":"10.1016\/j.gastha.2022.02.013_bib29","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201910375","article-title":"Repurposing the yellow fever vaccine for intratumoral immunotherapy","volume":"12","author":"Aznar","year":"2020","journal-title":"EMBO Mol Med"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572322000280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572322000280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T23:58:40Z","timestamp":1762646320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572322000280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"alternative-id":["S2772572322000280"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2022.02.013","relation":{},"ISSN":["2772-5723"],"issn-type":[{"type":"print","value":"2772-5723"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Heterologous Effects of Travel Vaccines in Colorectal Cancer: A Database Study and a Cautionary Tale","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2022.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute","name":"copyright","label":"Copyright"}]}}